Edition:
United Kingdom

Cigna Corp (CI.N)

CI.N on New York Stock Exchange

211.37USD
4:20pm BST
Change (% chg)

$0.17 (+0.08%)
Prev Close
$211.20
Open
$211.35
Day's High
$212.57
Day's Low
$209.94
Volume
72,495
Avg. Vol
532,997
52-wk High
$227.12
52-wk Low
$163.02

Chart for

About

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations... (more)

Overall

Beta: 0.47
Market Cap(Mil.): $48,077.03
Shares Outstanding(Mil.): 251.78
Dividend: 0.04
Yield (%): 0.02

Financials

  CI.N Industry Sector
P/E (TTM): 22.00 23.99 33.69
EPS (TTM): 8.68 -- --
ROI: -- -0.02 14.30
ROE: 16.12 16.38 16.03

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co , one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc , but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

UPDATE 1-Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Oct 17 Express Scripts Holding Co , one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

17 Oct 2018

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

10 Oct 2018

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

10 Oct 2018

UPDATE 3-CVS, Aetna win U.S. approval for $69 bln deal

WASHINGTON/NEW YORK, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers.

10 Oct 2018

CVS, Aetna win approval for merger

WASHINGTON, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination the companies say can help cut soaring U.S. healthcare costs.

10 Oct 2018

Summer lull hits U.S. loan fees despite Refinitiv deal

NEW YORK (LPC) - Bank fees earned from arranging US syndicated loans fell in the third quarter amid a summer lull as bankers awaited the US$13.5bn financing backing Blackstone’s US$20bn buyout of Refinitiv, the biggest buyout deal to test the markets since the financial crisis.

05 Oct 2018

Summer lull hits US loan fees despite Refinitiv deal

NEW YORK, Oct 5 (LPC) - Bank fees earned from arranging US syndicated loans fell in the third quarter amid a summer lull as bankers awaited the US$13.5bn financing backing Blackstone’s US$20bn buyout of Refinitiv, the biggest buyout deal to test the markets since the financial crisis.

05 Oct 2018

Competitors

  Price Chg
Anthem Inc (ANTM.N) $281.48 +1.90
Metlife Inc (MET.N) $44.52 -0.14
Metlife Inc (MET_pa.N) $23.96 -0.01
Metlife Inc (MLG) 38.00zł --
Aetna Inc (AET.N) $201.71 +0.42
UnitedHealth Group Inc (UNH.N) $265.79 -1.51
AFLAC Incorporated (AFL.N) $44.98 +0.26
Unum Group (UNM.N) $38.22 +0.23
Torchmark Corporation (TMK.N) $86.30 +0.47

Earnings vs. Estimates